Roche
ROG.SW
C$449.70
Share price
0.89%
Change (1 day)
18.74%
Change (1 year)
Categories
Roche (ROG.SW) - Total debt
Total debt on the balance sheet as of December 2024 : C$54.91 Billion
According to Roche's latest financial reports the company's total debt is C$54.91 Billion. A company’s total debt is the sum of all current and non-current debts.
Roche - Total debt on balance sheet (from 2006 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | C$57.75 B | 18.94% |
| 2023-12-31 | C$48.56 B | 24.55% |
| 2022-12-31 | C$38.98 B | -14.13% |
| 2021-12-31 | C$45.40 B | 103.7% |
| 2020-12-31 | C$22.28 B | 6.09% |
| 2019-12-31 | C$21.01 B | -19.18% |
| 2018-12-31 | C$25.99 B | 6.19% |
| 2017-12-31 | C$24.48 B | -16.99% |
| 2016-12-31 | C$29.49 B | -9.66% |
| 2015-12-31 | C$32.64 B | 8.15% |
| 2014-12-31 | C$30.18 B | 34.95% |
| 2013-12-31 | C$22.36 B | -16.52% |
| 2012-12-31 | C$26.79 B | -7.98% |
| 2011-12-31 | C$29.11 B | -9.44% |
| 2010-12-31 | C$32.15 B | -25.5% |
| 2009-12-31 | C$43.15 B | 805.21% |
| 2008-12-31 | C$4.76 B | -21.21% |
| 2007-12-31 | C$6.05 B | -23.3% |
| 2006-12-31 | C$7.88 B | -7.8% |
| 2005-12-31 | C$8.55 B | -10.62% |
| 2004-12-31 | C$9.57 B | -40.3% |
| 2003-12-31 | C$16.03 B | -63.43% |
| 2002-12-31 | C$43.84 B | -6.62% |
| 2001-12-31 | C$46.95 B | 16.72% |
| 2000-12-31 | C$40.23 B | 3.66% |
| 1999-12-31 | C$38.81 B | 1.07% |
| 1998-12-31 | C$38.39 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | C$71.29 B | 29.82% | 🇺🇸 USA |
 Merck MRK | C$47.54 B | -13.43% | 🇺🇸 USA |
 Pfizer PFE | C$83.63 B | 52.28% | 🇺🇸 USA |
 Sanofi SNY | C$31.07 B | -43.43% | 🇫🇷 France |
 Novartis NVS | C$42.66 B | -22.31% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | C$32.49 B | -40.83% | 🇬🇧 UK |
 Abbott Laboratories ABT | C$18.06 B | -67.10% | 🇺🇸 USA |
 Amgen AMGN | C$78.29 B | 42.57% | 🇺🇸 USA |
 Becton Dickinson BDX | C$26.29 B | -52.12% | 🇺🇸 USA |